Clinical Trials Browser

Phase 2 × Multiple Myeloma × Interleukin-2 × Clear all

NCT00006244 2017-07-12

Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma

Phase 2 Completed

36 enrolled 14 charts

Multiple Myeloma